SC-103b

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSC-103b
Drug Alias NameSC-103b
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action3',5'-cyclic phosphodiesterase inhibitors
Targets3',5'-cyclic phosphodiesterase
Therapy Area/IndicationsDiabetes ComplicationsErectile Dysfunction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesScotiaAsta Medica Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesScotiaAsta Medica Ag
Active IndicationsN/A
Inactive IndicationsDiabetes ComplicationsErectile Dysfunction

Other Information

ATC CodeN/A
Related LinksN/A